Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-year randomized double-blind placebo-controlled study of ranirestat in diabetic sensorimotor polyneuropathy
2008-002843-18Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ranirestat in diabetic peripheral polyneuropathy (DPN), diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Peroneal motor nerve conduction velocity. Started Jun 2009; status: completed.
02
Drugs
ranirestat
03
Conditions
diabetic peripheral polyneuropathy (DPN)diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002843-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002843-18.